Literature DB >> 9022555

Dietary sodium chloride and potassium have effects on the pathophysiology of hypertension in humans and animals.

L Tobian1.   

Abstract

A diet high in NaCl can raise blood pressure in susceptible people and animals, probably by similar mechanisms. The possibly harmful effects of a high-NaCl diet are not unexpected because both prehistoric humans and mammals evolved in a low-NaCl environment. Evolutionary forces molded mammals to adapt well to a low sodium intake; modern high NaCl intakes go against this adaptation. A high-NaCl diet can cause premature mortality by raising blood pressure in susceptible people. We have new evidence that in hypertension, a high-NaCl diet can cause a great increase in mortality even though it does not cause a further blood pressure rise, partially because of multiple small cerebral infarcts. Recent evidence also indicates that a high-potassium diet reduces the rise of blood pressure caused by a high-NaCl diet, whereas a low-normal potassium intake encourages an NaCl-induced blood pressure rise. The combination of a tendency by the kidneys to retain NaCl together with a high NaCl intake can produce a blood pressure rise. This combination tends to cause NaCl retention, which can trigger blood pressure rises in susceptible humans and animals. Such blood pressure rises can augment renal NaCl excretion and regain the previous NaCl balance. In Dahl salt-sensitive rats several renal abnormalities encourage sodium retention. By analogy, renal "abnormalities" are probably present in people susceptible to hypertension.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9022555     DOI: 10.1093/ajcn/65.2.606S

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  9 in total

1.  Population strategies to treat hypertension.

Authors:  Daniel T Lackland
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-08

2.  How does potassium supplementation lower blood pressure?

Authors:  Alicia A McDonough; Mien T X Nguyen
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-01

3.  TRPV4 deletion protects against hypokalemia during systemic K+ deficiency.

Authors:  Viktor Tomilin; Mykola Mamenko; Oleg Zaika; Charles S Wingo; Oleh Pochynyuk
Journal:  Am J Physiol Renal Physiol       Date:  2019-03-06

4.  Relationships between urinary electrolytes excretion and central hemodynamics, and arterial stiffness in hypertensive patients.

Authors:  Weizhong Han; Xiao Han; Ningling Sun; Yunchao Chen; Shiliang Jiang; Min Li
Journal:  Hypertens Res       Date:  2017-03-02       Impact factor: 3.872

5.  Effects of K+-deficient diets with and without NaCl supplementation on Na+, K+, and H2O transporters' abundance along the nephron.

Authors:  Mien T X Nguyen; Li E Yang; Nicholas K Fletcher; Donna H Lee; Hetal Kocinsky; Sebastian Bachmann; Eric Delpire; Alicia A McDonough
Journal:  Am J Physiol Renal Physiol       Date:  2012-04-11

Review 6.  Dietary electrolytes and hypertension in the elderly.

Authors:  T Rosenthal; A Shamiss; E Holtzman
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

7.  Potassium inhibits dietary salt-induced transforming growth factor-beta production.

Authors:  Wei-Zhong Ying; Kristal Aaron; Pei-Xuan Wang; Paul W Sanders
Journal:  Hypertension       Date:  2009-09-08       Impact factor: 10.190

8.  Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2.

Authors:  Carlos P Vio; Pedro Gallardo; Carlos Cespedes; Daniela Salas; Jessica Diaz-Elizondo; Natalia Mendez
Journal:  Front Pharmacol       Date:  2020-06-18       Impact factor: 5.810

9.  Salt loading and potassium supplementation: effects on ambulatory arterial stiffness index and endothelin-1 levels in normotensive and mild hypertensive patients.

Authors:  Zhendong Liu; Jie Peng; Fanghong Lu; Yingxin Zhao; Shujian Wang; Shangwen Sun; Hua Zhang; Yutao Diao
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-04-26       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.